Drugs for asthma.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D000280:Administration, Inhalation; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D000328:Adult; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000209:etiology / Q000517:prevention & control; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003521:Cyclopropanes; D015444:Exercise; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives / Q000627:therapeutic use; D007211:Indoles; D009241:Ipratropium / Q000627:therapeutic use; D007774:Lactation; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009330:Nebulizers and Vaporizers; D017835:Nedocromil / Q000627:therapeutic use; D048448:Phenylcarbamates; D011247:Pregnancy; D011248:Pregnancy Complications; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use; D000068299:Salmeterol Xinafoate; D013440:Sulfides; D013449:Sulfonamides; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use; D014105:Tosyl Compounds / Q000627:therapeutic use
D000085:Acetates; D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D003521:Cyclopropanes; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D011804:Quinolines; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds; D017835:Nedocromil; D000068299:Salmeterol Xinafoate; D013806:Theophylline; D009241:Ipratropium; C093875:montelukast; D004205:Cromolyn Sodium; D000420:Albuterol; C063449:zileuton; D006918:Hydroxyurea; C062735:zafirlukast